CANCER NEWS SOURCE

• share
• favorite_border

In a first-of-its-kind study, the American Cancer Society (ACS) today released “Cancer in People who Identify as Lesbian, Gay, Bisexual, Transgender, Queer or Gender-nonconforming (LGBTQ+)”. The article provides the latest statistics on the prevalence of cancer screening and modifiable risk factors in LGBTQ+ populations, as well as a review of literature on cancer occurrence and obstacles to cancer prevention and treatment.

• share
• favorite_border

Astatine-211 is a promising alpha emitter for targeted alpha therapy for cancer, but astatine is among the least-studied elements. In this research, scientists investigated astatine’s behavior when interacting with ion exchange and extraction chromatography resins used to produce radioisotopes and delivering them to targets in the body.

• share
• favorite_border

Moffitt Cancer Center, a world-renowned cancer treatment and research center, and Virogen Biotechnology Inc., a clinical-stage biotechnology company, announced a groundbreaking strategic partnership today. This collaboration aims to propel the development of Virogen's cutting-edge fusion protein, VG712 (Resimmune), addressing significant unmet needs in oncology and immunotherapy.

• share
• favorite_border

Researchers from The University of Texas MD Anderson Cancer Center presented positive clinical results from two studies today at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting.

• share
• favorite_border

A team of researchers at Children’s Hospital Los Angeles recently published a genomic study that uncovered two classes of genetic causes for chordoma in children by conducting some genomic detective work.

• share
• favorite_border

Gastrointestinal cancer surgeons at the UC San Francisco have performed the health system’s 15,000th robotically assisted minimally invasive surgery, making it the first University of California health center to reach this milestone. UCSF Health has the busiest robotic surgery program in the UC health system and is the leading academic medical institution for robotic surgeries in the western U.S.

• share
• favorite_border

• share
• favorite_border

Secondary analyses of a phase 3 clinical trial have revealed that breast cancer patients who reported high levels of pain and stress were more likely than their study peers to experience worse invasive disease-free survival (iDFS) and worse overall survival (OS).

• share
• favorite_border

Data from a large prospective cohort study reveal that a polygenic risk score has the potential to predict survival outcomes in patients with breast cancer.

• share
• favorite_border

New research from Yale Cancer Center reveals first-of-its-kind data from a phase I study in patients with hormone receptor positive HER2-negative metastatic breast cancer. The results, which assess the safety and efficacy of a treatment known as PF-07248144, offer new hope for treating this aggressive type of breast cancer.

• share
• favorite_border

A new study that examined the cost-effectiveness of durvalumab, a targeted immunotherapy for lung cancer, could help guide drug-pricing strategies to reduce financial burdens and increase the number of patients who benefit from treatment.

• share
• favorite_border

Researchers from Fred Hutch Cancer Center have found that active surveillance for prostate cancer patients with a low risk of progression is an effective alternative to immediate surgery or radiation to manage the disease.

• share
• favorite_border

Brain cancer is difficult to treat when it starts growing, and a prevalent type, known as a glioma, has a poor five-year survival rate.

• share
• favorite_border

A detecção precoce ajuda nos resultados do tratamento para os cânceres de endométrio e de ovário, mas muitas vezes as mulheres são diagnosticadas em fases avançadas dessas doenças. Ao contrário de muitos outros tipos de câncer, não existem exames padrões para a detecção precoce dos cânceres de endométrio e de ovário. É esperado que a taxa de incidência de câncer de endométrio aumente, impulsionada por fatores ambientais, de obesidade e diabetes.

• share
• favorite_border

La detección temprana ayuda en los resultados del tratamiento para los cánceres de endometrio y ovario, pero a menudo las mujeres son diagnosticadas en etapas avanzadas de estas enfermedades. A diferencia de muchos otros tipos de cáncer, no existen pruebas estándar para la detección temprana de los cánceres de endometrio y ovario. Se espera que aumente la tasa de incidencia de cáncer de endometrio, impulsada por factores ambientales, de obesidad y diabetes.

• share
• favorite_border

Four teams of Dana-Farber Cancer Institute investigators have found that people experience discrimination and bias in different ways and in more realms of cancer care than previously understood. The findings, in different studies, suggest that oncology professionals and the systems they work in have more work to do to adapt to the realities of increasing diversity and inclusion, not only in the patient population but also in the oncology workforce.

• share
• favorite_border